Publications
HCCI’s original reports powered by #HCCIdata

The Rising Cost of Specialty Drugs Drove Spending Increases for People with Multiple Sclerosis

The Rising Cost of Specialty Drugs Drove Spending Increases for People with Multiple Sclerosis

This issue brief investigates how the cost of prescription drugs affects the total cost of care for people with multiple sclerosis (MS). It decomposes total health care spending by category, specifically separating out spending on specialty drugs used to treat MS, called Disease Modifying Therapies (DMTs). The issue brief subsequently examines whether changes in spending on DMTs are due to changes in their use or their average cost.